Pulmonary Delivery of Peptide Drug Using Surface-modified Liposomes to Improve Systemic Absorption
We have investigated surface-modified liposomes (100-200 nm) for pulmonary delivery of a peptide drug.Chitosan oligosaccharide (oligoCS),polyvinyl alcohol with a hydrophobic anchor (PVA-R)or carbopol-wheat germ agglutinin conjugate (CP-WGA) were examined as surface modifiers.The effect of liposomal surface modification on the behavior of the liposomes on pulmonary administration were evaluated in vitro and in vivo.
Kohei Tahara Mitsutaka Murata Risako Onodera Hirofumi Takeuchi
Laboratory of Pharmaceutical Engineering, Gifu Pharmaceutical University, Gifu, 501-1196, Japan
国际会议
沈阳
英文
149-151
2016-04-28(万方平台首次上网日期,不代表论文的发表时间)